Newsroom

Industry News

22 Sep

NXT-ID’s Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie

Nxt-ID, Inc. (Nasdaq:NXTD and NXTDW) (“Nxt-ID” or the “Company”), a biometric authentication company focused on the growing m-commerce market, updates the “Wocket in Your Pocket” celebrity ad campaign, featuring former boxer and world champion in the lightweight and light middleweight weight classes, Vinny Pazienza (PAZ). View photo . Yesterday...

Read more

22 Sep

NAC Global Technologies (NACG) Awarded Ten Year Supply Agreement

NAC Global Technologies (OTCQB: NACG) today announced it has been awarded a ten year supply agreement for harmonic gearing with Legacy Press Company, a flexographic printing press manufacturer of Fort Mill, SC. The Company’s HGT drives are applied on Legacy’s line of narrow web label presses, providing 360 degree...

Read more

22 Sep

Calpian Set to Support Apple Pay for Merchants

Calpian, Inc. (OTCQB: CLPI), global mobile payments technology and processing company, is set to support Apple Pay™ and provide merchants with access to Apple’s new mobile payments ecosystem. The new and highly anticipated mobile payment system from Apple, Apple Pay will allow consumers to pay for goods and services...

Read more

22 Sep

NXT-ID (NXTD) Issues Shareholder Corporate Update

NXT-ID, Inc. (NASDAQ: NXTD), a biometric authentication company focused on the growing mobile commerce market, issues the following corporate shareholder update following the uplisting to NASDAQ and the recent funding. Letter from the CEO: NXT-ID recently completed an essential round of funding and joined the NASDAQ to support ramping...

Read more

22 Sep

Boston Therapeutics (BTHE) Signs Clinical Trial Agreement With Prestigious Joslin Diabetes Center for Phase III Study of BTI-320

360 Patients to Be Enrolled in Phase III Study at 10 Sites in Four Countries; BTI-320, a Non-Systemic Chewable Tablet, Represents a New Generation of Alpha Glycosidase Inhibitors Boston Therapeutics, Inc. (OTCQB: BTHE) (“Boston Therapeutics” or “the Company”), a developer of complex carbohydrate therapeutics to treat diabetes, has signed...

Read more

18 Sep

NAC Global Technologies Announces Successful Test of New Turbine Technology

NAC Global Technologies (OTCBB: NACG) today announced the successful first stage testing of its HGT Turbine Drive, a harmonic gearing transmission technology for fluid and wind turbine energy production. Mr. Vincent Genovese, Chairman and CEO of NAC, said, “We are very pleased to announce another milestone in NAC’s development...

Read more

18 Sep

Inovio to Present at Upcoming Investor Conferences

Inovio Pharmaceuticals, Inc. (INO) announced today CEO Dr. J. Joseph Kim will be presenting at two upcoming investor conferences in New York, NY: Biocentury’s NewsMakers in the Biotech Industry Conference and Bernstein’s Genes as Drugs Event. NewsMakers in the Biotech Industry September 26, 2014 2:30 PM ET Investor Presentation...

Read more

18 Sep

Capricor Presents Safety and Preliminary Efficacy Results From ALLSTAR Phase I Clinical Trial at TCT 2014

Capricor Therapeutics, Inc. (CAPR), a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases, presented an abstract entitled “ALLogeneic Heart STem Cells ToAchieve Myocardial Regeneration (ALLSTAR): The Six Month Phase I Safety Results” with an oral presentation by Dr. Raj R. Makker, M.D., of Cedars-Sinai...

Read more

17 Sep

Hydrocarb Energy Announces Significant Increases in Oil and Gas Reserves

– Company’s PV-10 value doubled and proved reserves increased more than 50% for the year ended 2014 — Recent infrastructure improvements to further increase oil and gas production  Hydrocarb Energy Corporation (HECC) recently reported substantial increases to its PV-10 oil and gas reserves. The company also recently commenced operations to...

Read more

Page 1 of 1712345...10...Last »

Latest Tweets